Atlas FDA

JUVEDERM HYALURONATE

FDA premarket approval P050047/S022 · decided 2012-02-24

Approval details

PMA number
P050047
Supplement
S022
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
JUVEDERM HYALURONATE
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2012-01-25
Decision date
2012-02-24
Days to decision
30 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
APPROVAL FOR THE ADDITION OF A NEW PRECAUTION STATEMENT: FAILURE TO COMPLY WITH THESE INSTRUCTIONS COULD RESULT IN NEEDLE DISENGAGEMENT AND/OR PRODUCT LEAKAGE AT TE LUER-LOCK NEEDLE HUB CONNECTION.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25